Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kaltura Inc (KLTR) vs Novo Nordisk A/S (NVO) Price & Performance

Kaltura IncTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Kaltura Inc vs Novo Nordisk A/S — how do they compare? Kaltura Inc trades at $1.63 (market cap $249.42M), while Novo Nordisk A/S trades at $45.9 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 833.3× Kaltura Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.

KLTRNVO
Market Cap
$249.42M$207.85B
Sector
TechnologyHealth
52-Week High
$1.89$63.98
52-Week Low
$1.08$35.29
Enterprise Value
$261.64M$222.55B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kaltura Inc

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)

Read more on KLTR

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO